![Bernard F. Tobin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernard F. Tobin
Präsident bei Crescendo Bioscience LLC
Aktive Positionen von Bernard F. Tobin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Crescendo Bioscience LLC
![]() Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Präsident | - | - |
Karriereverlauf von Bernard F. Tobin
Ehemalige bekannte Positionen von Bernard F. Tobin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
MYRIAD GENETICS, INC. | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
Ausbildung von Bernard F. Tobin
Iowa State University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 3 |
President | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
AMGEN INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
MYRIAD GENETICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Crescendo Bioscience LLC
![]() Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Bernard F. Tobin
- Erfahrung